• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Innova Captab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74713.0
  • ISIN : INE0DUT01020
1,021.10 -15 (-1.50%)
  • As on 06 Nov 2026 (EOD)
  • Today’s Low

    1,011.60
  • Today’s High

    1,040.00
  • Open

    1,039.80
  • Perv Close

    1,036.60
  • 52W Low

    622.00
  • 52W High

    1,353.50

Key Indicators

  • P/E(TTM)

    61.35

  • Mar.Cap (₹Cr.)

    5,843.24

  • Div & Yield %

    0.20

  • Book Value(₹)

    154.94

  • Debt-Equity Ratio

    -1.50

  • AGM Date

    06-Nov-2026

  • EPS

    16.68

  • P/E Ratio

    61.35

Financials Ratios

  • Debt-Equity Ratio

    0.38

  • Mar.Cap (₹Cr.)

    5,843.24

  • RONW (%)

    17.04

  • ROCE (%)

    18.76

Score Board

  • Equity (₹ in Cr.)

    57.22

  • BV (₹)

    154.90

  • Sales( ₹ in Cr.)

    1,298.81

  • NP (in Cr.)

    83.68

  • NP Var(%)

    -7.0

  • Div%

    20.0

  • CPS (₹)

    21.20

  • EPS (₹)

    14.60

  • Traded Value (₹ in Lakhs)

    5,934.80

  • 52 Week High

    1,353.50

  • 52 Week Low

    622.00

  • Price BSE

    1037.0

  • Price NSE

    1,037.00

  • Market Capital( in Cr.)

    5,934.80

  • P/C Ratio

    49.00

  • P/E Ratio

    70.90

  • Price Vs.BV

    14.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,298.81 958.06 864.93 858.67 785.46 410.66
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,298.81 958.06 864.93 858.67 785.46 410.66
Other Income 13.24 16.78 10.72 8.73 2.86 1.37
Stock Adjustments 2.28 11.34 1.35 1.48 -1.00 -1.64
Total Income 1,314.33 986.18 877.00 868.88 787.32 410.39
EXPENDITURE :            
Raw Materials 728.91 552.98 506.91 529.83 607.88 309.06
Power and Fuel Cost 26.12 15.07 11.58 9.42 7.90 5.48
Employee Cost 111.09 62.74 50.11 43.60 36.30 22.22
Other Manufacturing Expenses 249.89 189.58 163.40 157.91 11.67 5.25
Selling and Administration Expenses 31.67 17.52 19.77 17.66 16.63 9.57
Miscellaneous Expenses 2.04 9.22 6.54 3.21 5.57 2.96
Employee Benefit Expenses 111.09 62.74 50.11 43.60 36.30 22.22
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,149.72 847.11 758.31 761.63 685.95 354.54
Operating Profit 164.61 139.08 118.69 107.26 101.37 55.86
Interest 15.42 2.17 13.59 18.30 5.33 3.93
Gross Profit 149.19 136.91 105.10 88.96 96.04 51.93
Depreciation 37.37 17.02 11.40 10.66 7.40 5.59
Profit Before Tax 111.82 119.89 93.70 78.30 88.64 46.34
Current Tax 17.77 22.00 25.18 18.86 21.80 11.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 10.37 8.42 0.35 1.89 0.66 0.35
Reported Net Profit 83.69 89.47 68.16 57.55 66.18 34.50
Extraordinary Items 0.01 -0.06 -1.38 1.66 -0.01 0.11
Adjusted Net Profit 83.68 89.53 69.54 55.89 66.19 34.39
Adjustment below Net Profit -0.06 -0.22 0.28 -36.06 -0.17 -0.08
P & L Balance brought forward 377.96 288.71 220.28 198.78 132.78 98.35
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 11.45 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 450.15 377.96 288.71 220.28 198.78 132.78
Dividend 11.45 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 2.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 14.63 15.63 11.91 11.99 55.15 287.50
Earnings Per Share(Adj)-Unit Curr 14.63 15.63 11.91 - - -
Book Value 154.94 142.06 126.47 55.90 175.69 1,206.84
Book Value(Adj)-Unit Curr 154.94 142.06 126.47 - - -

Shareholding Pattern

  • Promoter Group

    50.90%

  • Public Share Holding

    49.10%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 29,127,371 50.90 29,127,371 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 29,127,371 50.90 29,127,371 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 483,099 0.84 483,099 49
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 739,962 1.29 739,962 1
Mutual Funds / UTI 4,954,377 8.66 4,954,377 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,270,540 9.21 5,270,540 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,447,978 20.01 11,447,978 67
2] Non Institution
Bodies Corporate 638,983 1.12 638,983 316
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 175,710 0.31 175,710 679
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 148,838 0.26 148,838 891
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,624,078 22.06 12,624,078 11
Individuals holding nominal share capital up to Rs. 1 lakh 3,061,750 5.35 3,061,750 34,581
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 221 0.00 221 1
Others 0 0.00 0 0
Sub Total 16,649,580 29.10 16,649,580 36,479
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 57,224,929 100.00 57,224,929 36,551

Company Background

Innova Captab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Innova Captab Ltd
  • BSE Code : 74713.0
  • ISIN : INE0DUT01020
  • Incorporation Year

    2005

  • Registered Office

    Office No 1513 Satra Plaza
    Plot No 19-20 Sector 19D Vashi, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-2564 2095

  • FAX

  • Chairman

    Manoj Kumar Lohariwala

  • Managing Director

    Vinay Kumar Lohariwala

  • Company Secretary

    NEEHARIKA SHUKLA

  • Auditor

    BSR & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Innova Captab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Innova Captab 1,023.30 1,312.06 1,298.81 61.35 10.78
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77